Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95,141 | 80,728 | 103,285 | 71,898 | 60,108 |
| Marketable Securities | 163,005 | 220,114 | 253,061 | 319,074 | 196,170 |
| Receivables | 33,654 | 37,502 | 34,811 | 39,879 | 66,955 |
| Inventories | 42,749 | 41,442 | 34,849 | 24,968 | 24,172 |
| TOTAL | $350,995 | $392,895 | $438,448 | $479,064 | $364,147 |
| Non-Current Assets | |||||
| PPE Net | 21,741 | 21,886 | 21,908 | 19,618 | 16,315 |
| Other Non-Current Assets | 17,287 | 17,940 | 18,585 | 14,100 | 12,500 |
| TOTAL | $39,028 | $39,826 | $40,493 | $33,718 | $28,815 |
| Total Assets | $390,023 | $432,721 | $478,941 | $512,782 | $392,962 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,067 | 18,458 | 11,562 | 2,758 | 1,627 |
| Accrued Expenses | 53,953 | 41,366 | 44,091 | 49,862 | 36,207 |
| TOTAL | $97,578 | $92,651 | $96,765 | $96,705 | $96,737 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 15,298 | 16,012 | 16,708 | 12,242 | 10,783 |
| TOTAL | $15,298 | $16,012 | $16,708 | $12,242 | $10,783 |
| Total Liabilities | $112,876 | $108,663 | $113,473 | $108,947 | $107,520 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 90,855 | 90,855 | 90,642 | 90,374 | 90,051 |
| Common Shares | 909 | 908 | 906 | 903 | 800 |
| Retained earnings | -1,330,467 | -1,272,239 | -1,217,049 | -1,165,470 | -1,107,550 |
| Other shareholders' equity | 540 | 953 | 708 | 85 | 103 |
| TOTAL | $277,147 | $324,058 | $365,468 | $403,835 | $285,442 |
| Total Liabilities And Equity | $390,023 | $432,721 | $478,941 | $512,782 | $392,962 |